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Background/introduction
MR guidance of High Intensity Focused Ultrasound
(MFgHIFU) ablation offers the possibility to determine
if complete tumor ablation has been established based
on imaging the non-perfused volume (NPV). For ther-
mal therapy, contrast enhanced (CE) imaging with a
gadolinium-based contrast agent is currently the golden
standard to quantify the NPV. A drawback of this
method is that gadolinium based intra-vascular contrast
agents interfere with HIFU therapy in two ways. First,
ablation can release toxic free gadolinium, by long-term
decomposition of the encapsulating chelate. Second, it
degrades the quality of MR-thermometry. Therefore,
even if residual viable tumor tissue is observed with CE-
MRI, the treatment cannot be continued. To address
this problem for HIFU interventions on the kidney, this
study explores other means of perfusion imaging, such
as Arterial Spin Labeling (ASL). Petros Martirosan’s
group at the University of Tubingen used Flow-sensitive
Alternating Inversion Recovery (FAIR) to image perfu-
sion in the kidneys without the use of contrast agents.
This in vivo study on a porcine model investigates if
ASL potentially allows to perform NPV measurements
during therapy and to continue the intervention if
incomplete ablation of the target volume is observed.
Methods
Image acquisition: An ablation in the renal cortex was
performed in an in vivo porcine model. The animal was
positioned decubitus right on a Sonalleve HIFU platform
(Philips Healthcare, Vantaa, Finland), was under general
anesthesia and mechanically ventilated. All scans were
performed on a clinical 1.5T MR scanner (Achieva,
Philips Healthcare, Best, The Netherlands). 7 treatment
cells of 4 mm in diameter each were ablated in a honey-
comb-like pattern. To image the NPV without the use
of contrast agents, single shot gradient recalled echo-
planar imaging of a coronal slice centered at the ablated
region was preceded by slice selective inversion and glo-
bal inversion (in an alternating fashion).
Imaging parameters: in-plane resolution: 3 × 3 mm2,
slice thickness: 5mm, TE/TR: 44/4500 ms, inversion time:
1200 ms, matrix size: 128 × 128, number of dynamics: 20,
slice selective inversion slice thickness: 10mm, non-selec-
tive inversion slice thickness: 300 mm. For the CE scan, a
3D FFE THRIVE sequence was used with an isotropic
resolution of 1.5mm, a TR of 5.4 ms, a TE of 2.6 ms, a flip
angle of 10, 2 averages and a reconstruction matrix of
512x512. Data analysis: Matlab (R2013b, The MathWorks,
Inc., Natick, MA, USA) was used to realign the individual
images, after which a subtraction per dynamic was per-
formed. The subtractions were subsequently summed.
Mevislab 2.4 (MeVis Medical Solutions AG, Bremen,
Germany) was used to draw contours of NPV.
Results and conclusions
Figure 1 shows the resulting FAIR images before and
after ablation. After ablation, the NVP is visible as a
dark area at the left of the kidney. Figure 2 shows the
corresponding CE image (golden standard). The yellow
contour delineates the NPV as seen in the FAIR image.
There is a clear correspondence in terms of location
and shape in the NPVs as observed in both images. The
NPV in the FAIR image is smaller than to the NPV in
the CE image, which is, considering the difference in
resolution, most likely due to a partial volume effect. The
preliminary results show good correspondence between
NPVs in the FAIR and CE images and therefore indicate
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FAIR to be a promising method to monitor the NPV pro-
gression in between the sonications. Future work is
focused on an improved spatial resolution and a reduc-
tion of the required acquisition of the FAIR scans.
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Figure 1 FAIR EPI image of the kidney, coronal orientation, before ablation (a) and after ablation (b). After ablation, the NPV is seen as a black
volume on the left side of the kidney.
Figure 2 CE image, coronal orientation, The NPV is clearly visible as
a black volume. The contour of the FAIR NPV is shown in yellow.
Both the location and shape are comparable, unlike the size, which
is smaller.
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